Inflammatory bowel disease (IBD) represents a group of multifactorial illnesses with increasing incidence worldwide. Crohn's disease (CD) and ulcerative colitis (UC) are the two most thoroughly defined phenotypes of IBD. IBD associated with primary sclerosing cholangitis (PSC) - a progressive biliary disease leading to cirrhosis and liver failure - is considered as specific IBD phenotype (also referred to as 'PSC - IBD') due to its clinical and pathophysiological characteristics. The aim of the experimental part of this thesis was to define specific features of PSC - IBD in the key areas of IBD pathogenesis. These are: microbiota composition, gut - barrier failure, genetic predisposition and aberrant cellular and antibody immune response. F...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Byron P Vaughn,1 Thomas Kaiser,2,3 Christopher Staley,2,3 Matthew J Hamilton,2 Jon Reich,1 Carolyn G...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Inflammatory bowel diseases (IBD) are an autoimmune illnesses affecting gastrointestinal tract. The ...
Inflammatory bowel diseases represent a group of chronic conditions characterized by relapsing infla...
AIM: To review the current literature for the specific clinical characteristics of inflammatory bowe...
Inflammatory bowel disease (IBD) is a group of chronically relapsing immune-related disorders, engag...
Inflammatory bowel disease (IBD) is a group of chronically relapsing immune-related disorders, engag...
Primary sclerosing cholangitis (PSC) is an immune-mediated, cholestatic liver disease characterized ...
Objective: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often leading...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often leading to end-sta...
BACKGROUND Although majority of patients with PSC have colitis (PSC-IBD) this is phenotypically d...
BACKGROUND Although majority of patients with PSC have colitis (PSC-IBD) this is phenotypically d...
Primary sclerosing cholangitis (PSC) is a common indication for liver transplantation (LT). Up to 25...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Byron P Vaughn,1 Thomas Kaiser,2,3 Christopher Staley,2,3 Matthew J Hamilton,2 Jon Reich,1 Carolyn G...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Inflammatory bowel diseases (IBD) are an autoimmune illnesses affecting gastrointestinal tract. The ...
Inflammatory bowel diseases represent a group of chronic conditions characterized by relapsing infla...
AIM: To review the current literature for the specific clinical characteristics of inflammatory bowe...
Inflammatory bowel disease (IBD) is a group of chronically relapsing immune-related disorders, engag...
Inflammatory bowel disease (IBD) is a group of chronically relapsing immune-related disorders, engag...
Primary sclerosing cholangitis (PSC) is an immune-mediated, cholestatic liver disease characterized ...
Objective: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often leading...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often leading to end-sta...
BACKGROUND Although majority of patients with PSC have colitis (PSC-IBD) this is phenotypically d...
BACKGROUND Although majority of patients with PSC have colitis (PSC-IBD) this is phenotypically d...
Primary sclerosing cholangitis (PSC) is a common indication for liver transplantation (LT). Up to 25...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...
Byron P Vaughn,1 Thomas Kaiser,2,3 Christopher Staley,2,3 Matthew J Hamilton,2 Jon Reich,1 Carolyn G...
Introduction: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with pr...